Ambulatory oxygen: why do COPD patients not use their portable systems as prescribed? A qualitative study

Elizabeth Arnold, Anne Bruton, Maggie Donovan-Hall, Angela Fenwick, Bridget Dibb, Elizabeth Walker, Elizabeth Arnold, Anne Bruton, Maggie Donovan-Hall, Angela Fenwick, Bridget Dibb, Elizabeth Walker

Abstract

Background: Patients with COPD on long term oxygen therapy frequently do not adhere to their prescription, and they frequently do not use their ambulatory oxygen systems as intended. Reasons for this lack of adherence are not known. The aim of this study was to obtain in-depth information about perceptions and use of prescribed ambulatory oxygen systems from patients with COPD to inform ambulatory oxygen design, prescription and management.

Methods: A qualitative design was used, involving semi-structured face-to-face interviews informed by a grounded theory approach. Twenty-seven UK community-dwelling COPD patients using NHS prescribed ambulatory systems were recruited. Ambulatory oxygen systems comprised cylinders weighing 3.4 kg, a shoulder bag and nasal cannulae.

Results: Participants reported that they: received no instruction on how to use ambulatory oxygen; were uncertain of the benefits; were afraid the system would run out while they were using it (due to lack of confidence in the cylinder gauge); were embarrassed at being seen with the system in public; and were unable to carry the system because of the cylinder weight. The essential role of carers was also highlighted, as participants with no immediate carers did not use ambulatory oxygen outside the house.

Conclusions: These participants highlighted previously unreported problems that prevented them from using ambulatory oxygen as prescribed. Our novel findings point to: concerns with the lack of specific information provision; the perceived unreliability of the oxygen system; important carer issues surrounding managing and using ambulatory oxygen equipment. All of these issues, as well as previously reported problems with system weight and patient embarrassment, should be addressed to improve adherence to ambulatory oxygen prescription and enhance the physical and social benefits of maintaining mobility in this patient group. Increased user involvement in both system development and service provision planning, could have avoided many of the difficulties highlighted by this study.

References

    1. Bridgelal RM, Grocott PR, Weir HC. Issues and challenges of involving users in medical device development. Health Expect. 2008;11:63–71. doi: 10.1111/j.1369-7625.2007.00464.x.
    1. Multidisciplinary Assessment of Technology Centre for Healthcare (MATCH) 2010. 20-2-2010.
    1. Duck A. Cost-effectiveness and efficacy in long-term oxygen therapy. Nurs Times. 2006;102:46–50.
    1. Eaton T, Lewis C, Young P, Kennedy Y, Garrett JE, Kolbe J. Long-term oxygen therapy improves health-related quality of life. Respir Med. 2004;98:285–293. doi: 10.1016/j.rmed.2003.10.008.
    1. Lacasse Y, Lecours R, Pelletier C, Begin R, Maltais F. Randomised trial of ambulatory oxygen in oxygen-dependent COPD. Eur Respir J. 2005;25:1032–1038. doi: 10.1183/09031936.05.00113504.
    1. Lehane E, McCarthy G. Medication non-adherence--exploring the conceptual mire. Int J Nurs Pract. 2009;15:25–31. doi: 10.1111/j.1440-172X.2008.01722.x.
    1. Restrepo RD, Alvarez MT, Wittnebel LD, Sorenson H, Wettstein R, Vines DL. et al.Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008;3:371–384.
    1. Croxton TL, Bailey WC. Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report. Am J Respir Crit Care Med. 2006;174:373–378. doi: 10.1164/rccm.200507-1161WS.
    1. Nonoyama ML, Brooks D, Guyatt GH, Goldstein RS. Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. Am J Respir Crit Care Med. 2007;176:343–349. doi: 10.1164/rccm.200702-308OC.
    1. Drummond MB, Wise RA. Oxygen therapy in COPD: what do we know? Am J Respir Crit Care Med. 2007;176:321–322. doi: 10.1164/rccm.200705-682ED.
    1. Albert P, Calverley PM. Drugs (including oxygen) in severe COPD. Eur Respir J. 2008;31:1114–1124. doi: 10.1183/09031936.00116707.
    1. Consultation on a strategy for services for chronic obstructive pulmonary disease (COPD) in England. 2010. Ref Type: Internet Communication 17-3-2010.
    1. Chiovitti RF, Piran N. Rigour and grounded theory research. J Adv Nurs. 2003;44:427–435. doi: 10.1046/j.0309-2402.2003.02822.x.
    1. Bryant A, Charmaz K. In: Handbook of grounded theory. Bryant A, Charmaz K, editor. London: Sage; 2007. Grounded Theory in historical perspective: an epistemological account; pp. 31–57.
    1. May C, Montori VM, Mair FS. We need minimally disruptive medicine. BMJ. 2009;339:b2803. doi: 10.1136/bmj.b2803.
    1. Kennedy A, Rogers A, Bower P. Support for self care for patients with chronic disease. BMJ. 2007;335:968–970. doi: 10.1136/bmj.39372.540903.94.
    1. Petty TL, Bliss PL. Ambulatory oxygen therapy, exercise, and survival with advanced chronic obstructive pulmonary disease (the Nocturnal Oxygen Therapy Trial revisited) Respir Care. 2000;45:204–211.
    1. Kim V, Benditt JO, Wise RA, Sharafkhaneh A. Oxygen therapy in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5:513–518. doi: 10.1513/pats.200708-124ET.
    1. Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax. 2008;63:831–838. doi: 10.1136/thx.2007.086041.
    1. George J, Kong DC, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest. 2005;128:3198–3204. doi: 10.1378/chest.128.5.3198.
    1. Sommavilla B, Jorgensen C, Jensen K. Safety, simplicity and convenience of a modified prefilled insulin pen. Expert Opin Pharmacother. 2008;9:2223–2232. doi: 10.1517/14656566.9.13.2223.
    1. Williams V, Bruton A, Ellis-Hill C, McPherson K. What really matters to patients living with chronic obstructive pulmonary disease? An exploratory study. Chron Respir Dis. 2007;4:77–85. doi: 10.1177/1479972307078482.
    1. Earnest MA. Explaining adherence to supplemental oxygen therapy: the patient's perspective. J Gen Intern Med. 2002;17:749–755. doi: 10.1046/j.1525-1497.2002.20218.x.
    1. Bury M. Chronic illness as biographical disruption. Sociol Health Illn. 1982;4:167–182. doi: 10.1111/1467-9566.ep11339939.
    1. Scharloo M, Kaptein AA, Weinman JA, Willems LN, Rooijmans HG. Physical and psychological correlates of functioning in patients with chronic obstructive pulmonary disease. J Asthma. 2000;37:17–29. doi: 10.3109/02770900009055425.
    1. Ringbaek T, Lange P, Viskum K. Compliance with LTOT and consumption of mobile oxygen. Respir Med. 1999;93:333–337. doi: 10.1016/S0954-6111(99)90314-1.
    1. Vogiatzis I, Stratakos G, Simoes DC, Terzis G, Georgiadou O, Roussos C. et al.Effects of rehabilitative exercise on peripheral muscle TNFalpha, IL-6, IGF-I and MyoD expression in patients with COPD. Thorax. 2007;62:950–956. doi: 10.1136/thx.2006.069310.
    1. Berton E, Antonucci R, Palange P. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis. 2001;56:418–422.
    1. Veazie PJ, Cai S. A connection between medication adherence, patient sense of uniqueness, and the personalization of information. Med Hypotheses. 2007;68:335–342. doi: 10.1016/j.mehy.2006.04.077.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever